CN3479056
Active
National Fractionation Agreement
The National Blood Authority holds a limited-tender contract worth AU$3,351,400,190 with CSL BEHRING (AUSTRALIA) PTY LTD for blood plasma products and plasma fractionation services under the National Fractionation Agreement, running from December 2017 to December 2026.
$3.4B
Contract Value
Contract Details
- Contract ID
- CN3479056
- Status
- active
- Financial Year
- FY18
- Category
- Healthcare Services(UNSPSC: 85100000)
Key Dates
- Publish Date
- 10 Jan 2018
- Signed Date
- 10 Jan 2018
- Start Date
- 31 Dec 2017
- End Date
- 30 Dec 2026
- Duration
- 9 years, 2 months
Procurement Information
- Procurement Method
- Limited tender
- Exemption Code
- BP
- Exemption Reason
- App A: 11. Blood plasma products or plasma fractionation services.
Supplier
CSL BEHRING (AUSTRALIA) PTY LTD
- ABN
- 48 160 734 761
- Entity Type
- Australian Private Company
- Location
- VIC
Agency
More from CSL BEHRING (AUSTRALIA) PTY LTD
National Supply arrangement for imported immunoglobulin products
$1.9BNational Blood Authority
Imported Plasma and Recombinant Products
$271.3MNational Blood Authority
Procurement of Imported Plasma and Recombinant Products (IPRP) - Idelvion
$73.6MNational Blood Authority
Imported Plasma and Recombinant Products (Factor XI Concentrate)
$8.3MNational Blood Authority
Pharmaceutical Products
$23KDepartment of Defence